Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$3.32B |
| 2 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$975M |
| 3 |
AABA
Altaba Inc
AABA
|
+$871M |
| 4 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$372M |
| 5 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$338M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.62B |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$1.02B |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$860M |
| 4 |
Microsoft
MSFT
|
+$594M |
| 5 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$517M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.12% |
| 2 | Healthcare | 4.92% |
| 3 | Financials | 4.07% |
| 4 | Consumer Discretionary | 3.64% |
| 5 | Communication Services | 3.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3301
Invesco Senior Loan ETF
BKLN
$6.81B
| $602K | ﹤0.01% |
26,000
+4,000
| +18% | +$93K |
|
3302
Chemed
CHE
$7.22B
| $601K | ﹤0.01% |
2,936
-5,076
| -63% | -$1.01M |
|
3303
CALL
Emcor
EME
$36B
| $601K | ﹤0.01% |
+9,200
| New | +$592K |
|
3304
PUT
Jack in the Box
JACK
$335M
| $601K | ﹤0.01% |
6,100
+4,400
| +259% | +$454K |
|
3305
PUT
Clorox
CLX
$12.7B
| $600K | ﹤0.01% |
4,500
-19,500
| -81% | -$2.63M |
|
|
WWE
3306
DELISTED
World Wrestling Entertainment
WWE
| $600K | ﹤0.01% |
29,399
-6,953
| -19% | -$144K |
|
3307
CALL
Ameriprise Financial
AMP
$48.8B
| $598K | ﹤0.01% |
4,700
-1,000
| -18% | -$127K |
|
3308
Independence Realty Trust
IRT
$4.07B
| $598K | ﹤0.01% |
60,617
+55,821
| +1,164% | +$530K |
|
3309
CALL
Silicon Motion
SIMO
$8.68B
| $598K | ﹤0.01% |
12,400
+8,000
| +182% | +$396K |
|
|
NVO
3310
Novo Nordisk
NVO
$209B
| $596K | ﹤0.01% |
27,806
| – | – |
|
3311
NRG Energy
NRG
$24.8B
| $595K | ﹤0.01% |
34,576
-43,725
| -56% | -$733K |
|
3312
CALL
IMAX
IMAX
$2.66B
| $594K | ﹤0.01% |
27,000
+9,100
| +51% | +$255K |
|
3313
Companhia Siderúrgica Nacional
SID
$1.23B
| $594K | ﹤0.01% |
276,487
+268,503
| +3,363% | +$599K |
|
3314
CALL
LKQ Corp
LKQ
$6.29B
| $593K | ﹤0.01% |
18,000
+16,900
| +1,536% | +$523K |
|
3315
CALL
Lexicon Pharmaceuticals
LXRX
$1.1B
| $593K | ﹤0.01% |
+36,000
| New | +$557K |
|
|
BCPC
3316
Balchem Corp
BCPC
$5.72B
| $593K | ﹤0.01% |
7,635
+6,676
| +696% | +$532K |
|
3317
PUT
Cullen/Frost Bankers
CFR
$10.2B
| $592K | ﹤0.01% |
6,300
+6,200
| +6,200% | +$572K |
|
3318
CALL
FMC
FMC
$1.33B
| $592K | ﹤0.01% |
9,339
-8,878
| -49% | -$572K |
|
3319
Graham Holdings Company
GHC
$5.02B
| $591K | ﹤0.01% |
987
+122
| +14% | +$73.1K |
|
|
FISV
3320
CALL
Fiserv Inc
FISV
$27.9B
| $587K | ﹤0.01% |
9,600
-1,200
| -11% | -$72.6K |
|
3321
PUT
Interactive Brokers
IBKR
$39.8B
| $587K | ﹤0.01% |
62,800
-85,200
| -58% | -$757K |
|
3322
CALL
MannKind Corp
MNKD
$1.32B
| $587K | ﹤0.01% |
416,180
+379,800
| +1,044% | +$489K |
|
|
GGP
3323
CALL
DELISTED
GGP Inc.
GGP
| $587K | ﹤0.01% |
24,900
+22,000
| +759% | +$507K |
|
3324
CALL
Everest Group
EG
$14.4B
| $586K | ﹤0.01% |
2,300
+300
| +15% | +$74K |
|
3325
PUT
SAP
SAP
$238B
| $586K | ﹤0.01% |
5,600
+3,400
| +155% | +$351K |
|
Similar funds
Barclays's Q2 2017 Portfolio in Review
As of Q2 2017, Barclays held 7,324 positions worth $93.4B, up 1.6% from $91.9B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Barclays's Q2 2017 filing shows 436 new, 3,303 increased, 2,734 reduced and 395 closed positions. Its largest new stake was Altaba Inc: 16,007,195 shares worth $872M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.62B.
By sector, the portfolio is most concentrated in Technology at 6.1% of assets, up from 5.7% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q2 2017 buy was Altaba Inc: 16,007,195 shares worth $872M.
- Barclays added most to Invesco QQQ Trust in Q2 2017, an estimated $3.32B increase.
- Barclays's biggest Q2 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.62B.
- Barclays fully exited Yahoo Inc in Q2 2017, selling an estimated $174M.
- Barclays's ten largest holdings make up 32% of its $93.4B portfolio in Q2 2017.
- Barclays opened 436 new positions and closed 395 in Q2 2017.
- Barclays's portfolio value rose 1.6% quarter-over-quarter to $93.4B.
Based on Barclays's 13F filing for Q2 2017, filed 14 Aug 2017.